Data / Drug companies / Avion Pharmaceuticals, LLC
Avion Pharmaceuticals, LLC: 13 products in the FDA NDC directory, labeler code 75854
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Avion Pharmaceuticals, LLC (labeler code 75854) lists 13 products in the FDA National Drug Code Directory, covering 2 finished drugs by generic name. By type: 13 prescription drugs. Its main marketing category is other unapproved drugs. The newest product started marketing on December 16, 2024.
The request: Watch Avion Pharmaceuticals, LLC (FDA labeler code 75854): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 75854
- Products in commercial distribution
- 13
- Packages
- 15
- Finished drugs by generic name
- 2
- Prescription products
- 13
- Over the counter products
- 0
- Flagged as original packager
- 7 of 7 products that carry the flag
- Started marketing in the last 12 months
- 0
- Earliest marketing start
- January 16, 2013
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Other unapproved drugs | 11 | 84.6% |
| New drug applications (NDA) | 2 | 15.4% |
Products by type
| Type | Products | Share |
|---|---|---|
| Prescription drugs | 13 | 100% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
| Drug | Products | Companies listing it |
|---|---|---|
| Carbidopa levodopa | 1 | 1 |
| Levonorgestrel and ethinyl estradiol | 1 | 19 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Capsule, gelatin coated | 5 | 38.5% |
| Tablet | 3 | 23.1% |
| Tablet, coated | 1 | 7.7% |
| Kit | 1 | 7.7% |
| Tablet, film coated | 1 | 7.7% |
| Capsule | 1 | 7.7% |
| Tablet, chewable | 1 | 7.7% |
Pharmacologic classes
FDA established pharmacologic classes of its products.
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Niferex | 75854-344 | Tablet | Other unapproved drugs | December 16, 2024 |
| Dhivy | 75854-701 | Tablet | New drug applications (NDA) | July 13, 2022 |
| Balcoltra | 75854-602 | Kit | New drug applications (NDA) | April 10, 2018 |
| Chromagen | 75854-320 | Capsule | Other unapproved drugs | January 10, 2017 |
| Nicomide | 75854-343 | Tablet | Other unapproved drugs | December 8, 2014 |
| Prenate Mini | 75854-315 | Capsule, gelatin coated | Other unapproved drugs | November 18, 2014 |
| Prenate Pixie | 75854-316 | Tablet, film coated | Other unapproved drugs | August 15, 2014 |
| Prenate Essential | 75854-313 | Capsule, gelatin coated | Other unapproved drugs | July 18, 2014 |
| Prenate Elite | 75854-314 | Tablet, coated | Other unapproved drugs | June 5, 2014 |
| Prenate dha | 75854-312 | Capsule, gelatin coated | Other unapproved drugs | June 5, 2014 |
| PRENATE Enhance | 75854-309 | Capsule, gelatin coated | Other unapproved drugs | September 17, 2013 |
| PRENATE Restore | 75854-308 | Capsule, gelatin coated | Other unapproved drugs | September 17, 2013 |
| Prenate Chewable | 75854-306 | Tablet, chewable | Other unapproved drugs | January 16, 2013 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.